Australian Clinical Labs (ASX:ACL) Short-Term Capital Lease Obligation : A$0.0 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Short-Term Capital Lease Obligation?

Australian Clinical Labs's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.0 Mil.

Australian Clinical Labs's quarterly Short-Term Capital Lease Obligation increased from Dec. 2022 (A$0.0 Mil) to Jun. 2023 (A$101.1 Mil) but then declined from Jun. 2023 (A$101.1 Mil) to Dec. 2023 (A$0.0 Mil).

Australian Clinical Labs's annual Short-Term Capital Lease Obligation increased from Jun. 2021 (A$70.4 Mil) to Jun. 2022 (A$94.8 Mil) and increased from Jun. 2022 (A$94.8 Mil) to Jun. 2023 (A$101.1 Mil).

Australian Clinical Labs Short-Term Capital Lease Obligation Historical Data

The historical data trend for Australian Clinical Labs's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Short-Term Capital Lease Obligation Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Short-Term Capital Lease Obligation

64.50

70.40

94.77

101.09

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial			-	94.77	-	101.09	-

Australian Clinical Labs Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Australian Clinical Labs Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines